1-93523471-C-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001164473.3(FNBP1L):c.322C>A(p.Leu108Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,451,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164473.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FNBP1L | NM_001164473.3 | c.322C>A | p.Leu108Met | missense_variant | Exon 4 of 17 | ENST00000271234.13 | NP_001157945.1 | |
FNBP1L | NM_001024948.3 | c.322C>A | p.Leu108Met | missense_variant | Exon 4 of 14 | NP_001020119.1 | ||
FNBP1L | NM_017737.5 | c.322C>A | p.Leu108Met | missense_variant | Exon 4 of 15 | NP_060207.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FNBP1L | ENST00000271234.13 | c.322C>A | p.Leu108Met | missense_variant | Exon 4 of 17 | 5 | NM_001164473.3 | ENSP00000271234.7 | ||
FNBP1L | ENST00000260506.12 | c.322C>A | p.Leu108Met | missense_variant | Exon 4 of 14 | 1 | ENSP00000260506.8 | |||
FNBP1L | ENST00000370253.6 | c.322C>A | p.Leu108Met | missense_variant | Exon 4 of 15 | 5 | ENSP00000359275.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000213 AC: 5AN: 234590Hom.: 0 AF XY: 0.0000158 AC XY: 2AN XY: 126600
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1451376Hom.: 0 Cov.: 30 AF XY: 0.0000111 AC XY: 8AN XY: 720902
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.322C>A (p.L108M) alteration is located in exon 4 (coding exon 4) of the FNBP1L gene. This alteration results from a C to A substitution at nucleotide position 322, causing the leucine (L) at amino acid position 108 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at